← Back to headlines
Analyst Reinstates Merck with 'Neutral' Rating and $125 Price Target
An analyst has reinstated coverage of Merck (MRK) with a 'Neutral' rating and set a price target of $125.
12 May, 19:01 — 12 May, 19:01
Sources
Showing 1 of 1 sources
